TY - JOUR
T1 - Can a supranational medicines agency restore trust after vaccine suspensions? The case of Vaxzevria
AU - Albanese, Andrea
AU - Fallucchi, Francesco
AU - Verheyden, Bertrand
N1 - Publisher Copyright:
Copyright: © 2022 Albanese et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2022/11/30
Y1 - 2022/11/30
N2 - Over the first half of March 2021, the majority of European governments suspended Astrazeneca’s Vaxzevria vaccine as a precaution following media reports of rare blood clots. We analyse the impact of the European Medicines Agency’s (EMA) March 18th statement assuring the public of the safety of Vaxzevria and the immediate reinstatement of the vaccine by most countries on respondents’ intention to get vaccinated. By relying on survey data collected in Luxembourg and neighbouring areas between early March and mid-April, we observe that the willingness to be vaccinated was severely declining in the days preceding the EMA statement. We implement a regression discontinuity design exploiting the time at which respondents completed the survey and find that the vaccine reinstatement substantially restored vaccination intentions.
AB - Over the first half of March 2021, the majority of European governments suspended Astrazeneca’s Vaxzevria vaccine as a precaution following media reports of rare blood clots. We analyse the impact of the European Medicines Agency’s (EMA) March 18th statement assuring the public of the safety of Vaxzevria and the immediate reinstatement of the vaccine by most countries on respondents’ intention to get vaccinated. By relying on survey data collected in Luxembourg and neighbouring areas between early March and mid-April, we observe that the willingness to be vaccinated was severely declining in the days preceding the EMA statement. We implement a regression discontinuity design exploiting the time at which respondents completed the survey and find that the vaccine reinstatement substantially restored vaccination intentions.
UR - http://www.scopus.com/inward/record.url?scp=85143180772&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0277554
DO - 10.1371/journal.pone.0277554
M3 - Article
C2 - 36449501
AN - SCOPUS:85143180772
SN - 1932-6203
VL - 17
JO - PLoS ONE
JF - PLoS ONE
IS - 11
M1 - e0277554
ER -